$author.xingMing_EN,$author.xingMing_EN. Interpretation of “expert consensus on blood transfusion after severe trauma”[J]. CHINESE JOURNAL OF TRAUMA, 2013, 29(8): 711-714.
［1］Evans JA, van Wessem KJ, McDougall D, et al. Epidemiology of traumatic deaths:comprehensive population-based assessment. World J Surg, 2010, 34(1):158-163.
［8］Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol, 2003, 23(1):17-25.
［9］Walker C, Ingram M, Edwards D, et al. Use of thromboelastometry in the assessment of coagulation before epidural insertion after massive transfusion. Anaesthesia, 2011, 66(1)：52-55.
［10］Young PP, Cotton BA, Goodnough LT. Massive transfusion protocols for patients with substantial hemorrhage. Transfus Med Rev, 2011, 25(4)：293-303.
［11］British Committee for Standards in Haematology, Stainsby D, MacLennan S, et al. Guidelines on the management of massive blood loss. Br J Haematol, 2006, 135(5)：634-641.
［12］Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med, 2009, 37(12)：3124-3157.
［13］Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev, 2009, 23(6)：231-240.
［14］Spinella PC, Perkins JG, Grathwohl KW, et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma, 2009, 66(4 Suppl)：S69-S76.
［16］CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010, 376(9734)：23-32.
［17］CRASH-2 collaborators, Roberts I, Shakur H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients:an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011, 377(9771)：1096-1101.
［18］Roberts I, Shakur H, Ker K, et al. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev, 2011, 19(1) ：CD004896.
［19］Perel P, Al-Shahi Salman R, Kawahara T, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury-a nested randomised, placebo-controlled trial. Health Technol Assess, 2012, 16(13)：1-54.
［20］Moltzan CJ, Anderson DA, Callum J, et al. The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework. Transfusion Med, 2008, 18(2)：112-120.
